Evaluating brain MRI scans with the help of artificial intelligence

Greece is just one example of a population where the share of older people is expanding, and with it the incidences of neurodegenerative diseases. Among these, Alzheimer's disease is the most prevalent, accounting for 70% of neurodegenerative disease cases in Greece. According to estimates published by the Alzheimer Society of Greece, 197,000 people are suffering from the disease at present. This number is expected to rise to 354,000 by 2050. Dr. Andreas Papadopoulos1, a physician and scientific coordinator at Iatropolis Medical Group, a leading diagnostic provider near Athens, Greece, explains the key role of early diagnosis: "The likelihood of developing Alzheimer's may be only 1% to 2% at age 65. But then it doubles every five years. Existing drugs cannot reverse the course of the degeneration; they can only slow it down. This is why it's crucial to make the right diagnosis in the preliminary stages--when the first mild cognitive disorder appears--and to filter out Alzheimer's patients2."